Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China flag China · Delayed Price · Currency is CNY
6.69
-0.08 (-1.18%)
Sep 2, 2026, 2:20 PM CST

SHE:300942 Statistics

Total Valuation

SHE:300942 has a market cap or net worth of CNY 2.74 billion. The enterprise value is 2.63 billion.

Market Cap2.74B
Enterprise Value 2.63B

Important Dates

The last earnings date was Friday, August 28, 2026.

Earnings Date Aug 28, 2026
Ex-Dividend Date Jun 3, 2026

Share Statistics

SHE:300942 has 405.08 million shares outstanding. The number of shares has increased by 6.82% in one year.

Current Share Class 405.08M
Shares Outstanding 405.08M
Shares Change (YoY) +6.82%
Shares Change (QoQ) -0.22%
Owned by Insiders (%) 22.58%
Owned by Institutions (%) 3.09%
Float 150.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.71
PB Ratio 3.11
P/TBV Ratio 3.27
P/FCF Ratio n/a
P/OCF Ratio 44.94
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 9.31
EV / EBITDA 53.45
EV / EBIT 198.31
EV / FCF n/a

Financial Position

The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.53.

Current Ratio 6.61
Quick Ratio 5.87
Debt / Equity 0.53
Debt / EBITDA 9.43
Debt / FCF -12,299.65
Interest Coverage 0.97

Financial Efficiency

Return on equity (ROE) is -0.67% and return on invested capital (ROIC) is 1.74%.

Return on Equity (ROE) -0.67%
Return on Assets (ROA) 0.57%
Return on Invested Capital (ROIC) 1.74%
Return on Capital Employed (ROCE) 0.97%
Weighted Average Cost of Capital (WACC) 6.46%
Revenue Per Employee 520,862
Profits Per Employee -15,356
Employee Count542
Asset Turnover 0.19
Inventory Turnover 1.89

Taxes

Income Tax -5.70M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -51.74% in the last 52 weeks. The beta is 0.53, so SHE:300942's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change -51.74%
50-Day Moving Average 6.37
200-Day Moving Average 8.26
Relative Strength Index (RSI) 51.06
Average Volume (20 Days) 10,807,007

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:300942 had revenue of CNY 282.31 million and -8.32 million in losses. Loss per share was -0.02.

Revenue282.31M
Gross Profit 171.50M
Operating Income 13.25M
Pretax Income -11.52M
Net Income -8.32M
EBITDA 49.17M
EBIT 13.25M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 584.16 million in cash and 463.65 million in debt, with a net cash position of 120.51 million or 0.30 per share.

Cash & Cash Equivalents 584.16M
Total Debt 463.65M
Net Cash 120.51M
Net Cash Per Share 0.30
Equity (Book Value) 880.45M
Book Value Per Share 2.16
Working Capital 673.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.02 million and capital expenditures -61.06 million, giving a free cash flow of -37,696.

Operating Cash Flow 61.02M
Capital Expenditures -61.06M
Depreciation & Amortization 35.92M
Net Borrowing 21.44M
Free Cash Flow -37,696
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross margin is 60.75%, with operating and profit margins of 4.69% and -2.95%.

Gross Margin 60.75%
Operating Margin 4.69%
Pretax Margin -4.08%
Profit Margin -2.95%
EBITDA Margin 17.42%
EBIT Margin 4.69%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.37%.

Dividend Per Share 0.02
Dividend Yield 0.37%
Dividend Growth (YoY) 41.51%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.82%
Shareholder Yield -6.46%
Earnings Yield -0.30%
FCF Yield -0.00%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5